| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.35 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |